Skip to main content

Paradigm Biocapital Advisors LP

SEC CIK
0001855655
Latest filing
Aug 14, 2026

MDGL holding history

Madrigal Pharmaceuticals, Inc. in every 13F filed by Paradigm Biocapital Advisors LP, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

MDGL overviewAll 13F holders of MDGLFull Q2 2026 holdings

Shares (Q3 2023)
0
Sold out in Q3 2023
Value
$0
% of portfolio
0.0%
Quarters held
1
Since Q2 2023
Holdings of MDGL by Paradigm Biocapital Advisors LP, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q3 20230$00.0%−85,000−100.0%Sold outHolders
Q2 202385,000$19.6M1.6%+85,000NewHolders